Primed for a break out, page-11

First 11 Last

Share
Profile

Follow
1_Day_Man

778 Posts.

14

25/01/24

22:48

Post #: 72074329
Share

Originally posted by jdpc35: ↑

Auto.

I would not call myself a TA guru, but I do like to look at the charts to get a sense of where a stock has been and where it may be heading. For reference, I tend to use Eliott Wave as my primary method and so the below speaks to my interpretation from an EW approach.

I agree that this has broken out and as per my 3 year chart below, I have interpreted this as the commencement of an Eliott Wave 3 (which is certainly the "Wave" you want to catch). In my opinion, the low of 7.2c in March 2020 was the end of a long downward trend and since then we have seen a clear 5 wave impulse wave (collectively comprising what I have labelled as Wave 1) from that low to the Jan/Feb 2022 high of 21.5c - so an upward move of 14.3c in total. We have since been in a corrective Wave 2 that concluded with the 10.5c low in Dec 2023 (a decline of 11.0c or 77% of the Wave 1 upward move, which is very close to a classic 78.6% Fib retracement). Supporting this is the break of the downtrend that has existed since early 2022.

On this larger scale picture, I am interpreting that we are now in Wave 3 and so my target is a total move of 162% of Wave 1 (this being a classic Fib extension level and what you generally look for after a 61.8% or 78.6% retracement). This then suggests a target of 14.3c x 162% = +23.2c from the recent 10.5 low = a target of circa 33.7c (so in a ASX sense, we are talking circa 33c to 34c).

On a fundamental basis, this share price target lines up quite nicely with prospective valuation. If I apply a 4.5x multiple to my current expectation of BOL's FY24 EBITDA of $46m (inclusive of Right to Use) and then deduct net debt, I get an equity value of $137m and a target share price of 32c. I have used 4.5x multiple as this approximates the multiple at which the takeover of BLY has seemingly been pitched on my back of the envelope analysis.

Note, if BOL upgrade their FY24 forecast when they present the half year, then the above EBITDA I have used would need to be adjusted.

If this is indeed Wave 3, we should start to see some really significant upward movements in share price in relatively short timeframes. Half year update could well be the impetus for this.

Expand

pull this into a monthly and go back 5plus years

BOL Price at posting: 13.5¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

There are more pages in this discussion • 28 more messages in this thread...

First 11 Last

Add BOL (ASX) to my watchlist

(20min delay)
Last 14.5¢		Change 0.000(0.00%)		Mkt cap ! $61.34M

Open	High	Low	Value	Volume
14.5¢	15.0¢	14.5¢	$88.53K	597.7K

Buyers (Bids)

No.	Vol.	Price($)
5	273955	14.5¢

Sellers (Offers)

Price($)	Vol.	No.
15.0¢	372386	9

View Market Depth

No.	Vol.	Price($)
5	273955	0.145
4	233131	0.140
4	231249	0.135
5	418908	0.130
4	219000	0.125

Price($)	Vol.	No.
0.150	372386	9
0.155	230000	3
0.160	259772	4
0.165	493018	2
0.170	70881	2

Last trade - 16.10pm 23/05/2024 (20 minute delay)


Last 15.0¢		Change 0.000 ( 3.45 %)
Open	High	Low	Volume
14.5¢	15.0¢	14.5¢	57974
Last updated 12.07pm 23/05/2024 ?

BOL (ASX) Chart

Primed for a break out, page-11

Featured News

Market Close: Materials drag ASX into the red as IT climbs on a steady trajectory

Venture hits 1,839 TREO at Jupiter in WA with best intersection to date

Rock chips of more than 58% manganese guide Black Canyon's future drilling at Wandanya

KalGold hits more than 3g/t gold at Wessex target in WA

AFT Pharma reports record earnings, boosted sales and significant launches in US

Buyers (Bids)

Sellers (Offers)

Featured News

Primed for a break out, page-11

Featured News

Top Stories

Market Close: Materials drag ASX into the red as IT climbs on a steady trajectory

Venture hits 1,839 TREO at Jupiter in WA with best intersection to date

Rock chips of more than 58% manganese guide Black Canyon's future drilling at Wandanya

KalGold hits more than 3g/t gold at Wessex target in WA

AFT Pharma reports record earnings, boosted sales and significant launches in US

Buyers (Bids)

Sellers (Offers)

Featured News